Amedisys Balance Sheet Health
Financial Health criteria checks 3/6
Amedisys has a total shareholder equity of $1.1B and total debt of $377.5M, which brings its debt-to-equity ratio to 35.6%. Its total assets and total liabilities are $2.0B and $921.6M respectively. Amedisys's EBIT is $168.4M making its interest coverage ratio 6.9. It has cash and short-term investments of $95.4M.
Key information
35.6%
Debt to equity ratio
US$377.46m
Debt
Interest coverage ratio | 6.9x |
Cash | US$95.38m |
Equity | US$1.06b |
Total liabilities | US$921.65m |
Total assets | US$1.98b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AMED *'s short term assets ($426.5M) do not cover its short term liabilities ($462.4M).
Long Term Liabilities: AMED *'s short term assets ($426.5M) do not cover its long term liabilities ($459.2M).
Debt to Equity History and Analysis
Debt Level: AMED *'s net debt to equity ratio (26.6%) is considered satisfactory.
Reducing Debt: AMED *'s debt to equity ratio has increased from 30.5% to 35.6% over the past 5 years.
Debt Coverage: AMED *'s debt is well covered by operating cash flow (30.2%).
Interest Coverage: AMED *'s interest payments on its debt are well covered by EBIT (6.9x coverage).